Pathogenesis of secondary hyperparathyroidism

Kidney and Blood Pressure Research

Volumn 20, Issue 3, 1997, Pages 154-156

  Drüeke, Tilman ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; CALCITRIOL; PHOSPHATE;

ACIDOSIS; CALCIUM DEFICIENCY; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; CONFERENCE PAPER; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; UREMIA; VITAMIN D DEFICIENCY;

EID: 0030880047     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000174130     Document Type: Article

References (34)

1. Driieko T. Kubrusly: Pathogenesis of secondary hyperparathyroidism of chronic renal failure (Editorial). J Nephrol 1994;7:139-147.
2. Kifor O, Moore FD. Wang P. et al.: Reduced im-munostaining fortheextracellularCa' -sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Mctab 1996;81:1598-1606.
3. Gogusev J. Duchambon P. Hory B. Giovannini M. Sarfati E. Driiekc TB: Depressed expression of calcium receptor in parathyroid gland tissue of patients with primary or secondary uremic hyperparathyroidism. Kidney Int 1997:51:328-336.
4. Fukuda N. Tanaka H. Tominaga Y, Fukagawa M. Kurokawa K. Seino Y: Decreased 1.25-dihy-droxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 1993:92:1436-1442.
5. Patel S, Ke HO. Vanholdcr R. Hsu CH: Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafiltrate. Kidney hit 1994:46:129-133.
6. Patel SR. Ke HQ, Vanholder R. Koenig RJ. Hsu CH: Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 1995;96:50-59.
7. Morrison NA. Qi JC. Tokita A. Kelly PJ. Crofts L. Nguyen TV. Sambrook PN. Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 1997:387:106.
8. Carling T. Kindmark A. Hcliman P. Holmberg L. Äkerström G. Rastad J: Vitamin D receptor alleles b, a, and T: Risk factors for sporadic primary hyperparathyroidism (HPT) but not UPTof uremia of MEN I. Biochem Biophys Res Commun 1997;231:329-332.
9. Fernandez A, Fibla L. Bctriu A. Piulats JM. Al-mirall J. Montoliu J: Association between vitamin D receptor gene polymorphism and relative hypoparathyroidism in patients with chronic renal failure. J Am Soc Nephrol, in press.
10. Almadén Y. Canalojo A. Hernandez A. Balles-tros E. Garcia-Navarro S. Torres A. Rodriguez M: Direct effect of phosphorus on parathyroid hormone secretion from whole rat parathyroid glands in vitro. J Bone Miner Res 1996:11:970-976.
11. Slatopolsky E. Finch J. Denda M. Ritter C. Zhong M. Dusso A, Mac Donald PN, Brown AJ: Phosphorus restriction prevents parathyroid gland growth: High phosphorus directly stimulates PTH secretion in vitro., J Clin Invest 1996:97:2534-2540.
12. Nielsen PK. Feldt-Rasmussen U, Olgaard K: A direct effect of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nephrol Dial Transplant 1996: 11: 1762-1768.
13. Naveh-Many T, Rahamimov R, Livni N, Silver J: Parathyroid cell proliferation in normal and chronic renal failure rats: The effects of calcium. phosphate, and vitamin D., J Clin Invest 1995;96:1786-1793.
14. Corrèze MC. Gogusev J. Bourdeau A, Sarfati E, Drücke T: In vitro regulation of PTH synthesis' secretion and parathyroid (PT) cell ('H)-thymi-dine uptake by calcium and calcitriol in human PT tissue (abstract). J Am Soc Nephrol 1995:6: 958.
15. Roussanne MC. Gogusev J. Sarfati E. Drüeke T. Bourdeau A: Effect of phosphate on PTH secretion and proliferation in human parathyroid cells in culture (abstract). J Bone Miner Res 1997. in press.
16. Szabo A. Merke J, Beier E. Mall G. Ritz E: 1,25(011); vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int 1989;35:1045-1056.
17. Arnold A. Brown MF, U reft a P, Gaz RD. Sarfati E. Drüeke TB: Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995:95: 2047-2054.
18. Tominaga Y. Kohara S, Namii Y. Nagasaka T. I laba T. Uchida K. Numano M, Tanaka Y. Taga-ki H: Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism. World J Surg 1996:20:744-752.
19. Lubenskv LA. Delebenko LV, Zhuang ZP. Em-mcrebuck MR. Dong QH. Chandrasckharappa S. Gum SC. Manickham D. Olufcmi SE. Marx SJ, Spiegel AM. Collins FS, Liotta LA: Allelic deletions on chromosome I Iq 13 in multiple tumors from individual MEN I patients. Cancer Res 1996:56:5272-5278.
20. Inagaki C. Dousscau M. Pachcr N. Sarfati E. Drüeke T, Gogusev J: Structural analysis of gene marker loci on chromosomes It and 11 in primary (1°) or secondary (II) hyperparathyroidism (HPTH) (abstract Al 168)., J Am Soc Nephrol 1996:7:1483.
21. Famebo F. Teh BT. Dotzenrath C. Wassil WS. Svennson A, White I. Betz R. Goretzki P. San-delin K. Farnebo L-O. Larsson C: Differential loss of heterozygosity in familial, sporadic, and uremic hyperparathyroidism. Hum Genet 1997: 99:342-349.
22. Drüeke TB: Abnormal skeletal response to PTH and PTH receptor expression in chronic uremia. Pcdiatr Nephrol 1996:10:348-350.
23. Cohen-Solal ME. Boudailliez B. Sebert JL. Westeel PF. Bouillon R. Fournier A: Comparison of intact, mid region and carboxyterminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. J Clin Endocrinol Mctab 1991;73:516-524.
24. Quarles LD. Lobaugh B. Murphy G: Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Mctab 1992:75:145-150.
25. Fournier A. Oprisiu R. Fspcr NE, Morinière P: Optimal plasma concentrations of intact parathyroid hormone in prcdialysis patients. Nephrol Dial Transplant 1995:10:2376-2377.
26. Urena P. Kubrusly M. Mannstadt VI, Hrnby M. Trinh Trang Tan MM. Silve C, Lacour B. Abon-Samra A. Seyre G. Drüeke T: The renal PTH PTIIrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 1994:45:605-611.
27. Smogorzewski M. Tian J. Massry SG: Down-regulation of PTH-PTHrP receptor of heart in CRF: Role of [C\r],. Kidney Int 1995:47: 1182-1186.
28. Urena P. Ferreira A. Morieux C. Drüeke TB. Vemejoul MC de: PTH PTIIrP receptormRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 1996; 11:2008-2016.
29. Moore PR. Gokal R. Hoyland JA: Bone biopsy Beyond light microscopy and histodynantics. Nephrol Dial Transplant 1997:12:659-663.
30. Wang Q. Palnitkar S, Parfitt AM: Parathyroid cell proliferation in the rat: Effect of age and of phosphate administration increases both size and number of and recovery. Endocrinology 1996; 137:4558-4562.
31. Zhang P. Gogusev J. Duchambon P. Sarfati E, Drüeke T: Apoptosis in patients with primary (1°) or secondary (11°) hyperparathyroidism (HPTH) (abstract A1279). J Am Soc Nephrol 1996:7:1504.
32. Sugenoya Y. Yoshimura A. Uda S. Inui K. Iwa-saki S. Taira T, Idmra T: Expression of apoptosis-preventing bel-2 and its counteractive box is associated with cell proliferation in secondary hyperparathyroidism (II-FIPT) (abstract)., J Am Soc Nephrol 1996;7.
33. Olivetti G. Abbi R, Quaini F. Kajustra J, C'hcng W. Nitahara JA. Quaini E. Diloreto C, Beltrami CA. Krajewski S. Reed JC. Anversa P: Apoptosis in the failing human heart. N Engl J Med 1997:336:1131-1141.
34. Parfitt AM: Hypercalcémie hyperparathyroidism following renal transplantation: Differential diagnosis, management and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 1982:8:92-112.